U.S. Healthtech Stock News

Ralph Lauren stock has delivered a very strong 5 year run, yet current valuation checks suggest the shares are trading at a premium to what its intrinsic value models and market multiples imply. Ralph Lauren has returned about 285.4% over the past 5 years, which puts recent gains front and center when judging whether the current price still offers an attractive entry point. Recent revenue momentum and brand investment can support optimistic expectations, but there are concerns about the...

Index removals and fresh debt plans put Prestige Consumer Healthcare in focus Prestige Consumer Healthcare (PBH) has drawn attention after being removed from several Russell growth indices, while its subsidiary Prestige Brands moves ahead with a new senior notes offering and a concurrent debt redemption plan. See our latest analysis for Prestige Consumer Healthcare. The share price of Prestige Consumer Healthcare closed at US$47.27, with a 7 day share price return of 2.65%, a 90 day share...

Index removal puts Assured Guaranty in focus Assured Guaranty (AGO) was recently dropped from the Russell 1000 Dynamic Index, an event that can reshape trading flows as index funds adjust holdings and some investors reassess their exposure. See our latest analysis for Assured Guaranty. Against the backdrop of its removal from the Russell 1000 Dynamic Index, Assured Guaranty’s recent trading has been mixed, with an 8.0% 1 month share price return contrasting with a year to date decline of 9.7%...

In recent weeks, Starbucks began construction on a new store at Russell Centre, reinforcing the center’s role as a retail and community hub while extending the coffee chain’s already large global footprint of more than 41,000 locations. This expansion aligns with Starbucks’ push to reestablish its “third place” concept through thousands of planned smaller-format U.S. stores, emphasizing convenience, community appeal, and increased daily customer traffic for surrounding tenants. We’ll now...

In June 2026, a key FDA advisory committee unanimously recommended approval of Moderna’s mRNA-based influenza vaccine, mFlusiva (mRNA-1010), for adults aged 50 and older after late-stage data showed it was about 27% more effective than a standard flu shot. This vote not only advances what could become the first mRNA flu vaccine but also reinforces confidence in Moderna’s broader shift beyond COVID-19 into respiratory, oncology, and rare-disease applications of its mRNA platform. We’ll now...

Index additions put National Vision Holdings in focus National Vision Holdings (EYE) was recently added to several Russell growth benchmarks, including the Russell 2000 Growth and Russell 3000 Growth, an index change that can reshape how institutions and index funds approach the stock. See our latest analysis for National Vision Holdings. The index additions come after a sharp short term rebound in National Vision Holdings, with a 7 day share price return of 13.29% and 30 day share price...

After a difficult year in which Intuit stock has fallen 66.2%, the valuation picture now looks more forgiving on several checks, even as legal questions and AI driven competition keep many investors cautious. Over the past 12 months, Intuit shares are down 66.2%, which has reset expectations and brought valuation to the forefront for anyone still following the story. Ongoing restructuring and AI investment may support future earnings power, but securities fraud investigations around TurboTax...

In late June 2026, XPO, Inc. (NYSE:XPO) was removed from several Russell indices, including the Russell 3000 Value, Russell 2500, and Russell 1000 Value benchmarks, following the annual reconstitution. This broad index removal reshapes who can hold the stock in index-tracking portfolios, potentially altering XPO’s institutional investor mix and trading patterns. We’ll now examine how XPO’s broad removal from Russell indices may influence its existing investment narrative around technology,...

IonQ stock has delivered a very strong 5 year return, yet its current valuation screens as expensive, so investors are now weighing a powerful growth story against a set of signals that point to a rich price tag. IonQ has returned about 406% over the past 5 years, which puts recent swings into context and shows how stretched sentiment can become after a long run. On the one hand, ambitious quantum computing and security ambitions backed by sizeable cash reserves can support high...

Par Pacific Holdings Stock Performance Snapshot Par Pacific Holdings (PARR) has drawn investor attention after recent trading, with the stock last closing at US$56.08. Returns have been mixed, with gains over the past week but a decline over the past 3 months. See our latest analysis for Par Pacific Holdings. Looking beyond the latest move, Par Pacific Holdings shows a strong year-to-date share price return of 56.56%, while its 1-year total shareholder return of 99.15% points to momentum that...

Index removals reshape how some investors access Wayfair stock Wayfair (W) was removed from several Russell growth benchmarks on June 27, a shift that can affect index linked fund holdings and help explain any unusual trading around the stock. For investors, index deletions like this matter because many institutional portfolios and passive funds track these benchmarks and adjust their positions mechanically. When a stock exits multiple indices at once, related buying or selling can cluster...

Hesai Group recently attracted investor attention as optimism grew around its advanced LiDAR technology and its role in autonomous mobility and ADAS markets. Beyond the technology itself, investors appear focused on Hesai’s solid cash position and momentum among buyers as potential supports for its expansion plans. We’ll now examine how this renewed confidence in Hesai’s LiDAR adoption prospects may influence the company’s existing investment narrative and risks. The best AI stocks today may...

US lawmakers have opened a bipartisan investigation into AbbVie (NYSE:ABBV) over clinical trial activity in China. The probe focuses on possible national security and ethical risks, including research ties to facilities linked to China's military. Congress is also scrutinizing AbbVie trials in sensitive regions such as Xinjiang and potential exposure of patient and research data. AbbVie is a large US-based pharmaceutical company with a global footprint in drug development and clinical...

Albany International Corp. was recently added to the Russell 2000 Dynamic Index, formally recognizing the company as part of this widely followed small‑cap benchmark. This index inclusion could broaden Albany’s investor base and trading liquidity, potentially making its engineered composites and machine clothing businesses more visible to institutional investors. With Albany now in the Russell 2000 Dynamic Index, we’ll examine how this broader visibility may influence its existing investment...

Herbalife stock has delivered a steep decline of around 75% over the past five years, yet on current checks it screens as undervalued, which sets up a clear question over whether recent share price strength is finally bringing it closer to a more reasonable level or leaving some upside on the table. Over the past five years, Herbalife shareholders have seen the share price fall about 75%, which means even the recent rebound sits against a long period of value erosion. The new Herbalife and...

Carpenter Technology has delivered very large multi year gains for shareholders, yet its latest valuation checks flag the stock as expensive rather than a clear bargain. After a sharp run, investors are weighing rich pricing against strong aerospace related momentum highlighted in recent commentary. Carpenter Technology has returned about 16.4x over the past 5 years, which puts extra focus on whether today’s price still leaves room for an attractive risk return trade off. Recent investor...

What Photronics’ Index Additions Could Mean for Investors Photronics (PLAB) has been added to multiple Russell growth and small cap benchmarks, an event that can attract index-linked capital as funds rebalance and traders reassess the stock’s role in portfolios. See our latest analysis for Photronics. Recent trading suggests momentum for Photronics has cooled over the past quarter, with the share price down 20.37% over 90 days. However, the 1-year total shareholder return is 61.44%, which...

Johnson & Johnson reported new clinical data for IMAAVY (nipocalimab) in generalized myasthenia gravis, including sustained improvement in early stage and less symptomatic patients. The data also showed maintained disease control following infections, a key issue for long-term treatment persistence in this condition. The company announced plans for PETUNIA, a real-world pregnancy safety study, to build evidence on IMAAVY use during pregnancy. Johnson & Johnson, traded as NYSE:JNJ, is...

Energy Transfer has delivered a very strong 166.2% return over the past 5 years, yet on most basic valuation checks the stock still screens as inexpensive. This raises a clear question about how much of its recent progress is already reflected in the price. A 166.2% gain over 5 years suggests Energy Transfer has already rewarded long term holders. Any new position or added exposure therefore rests on whether that momentum can be justified by current and future cash flows. Growth projects...

With housing policy gridlock, rising energy costs, and pressure on household budgets from higher healthcare premiums and tariffs, real estate investment trusts are caught in the crosscurrents of some powerful macro forces. The REITs screener used here focuses on larger companies in the US, UK, Canada, Australia, and New Zealand with solid balance sheet and dividend characteristics and direct links to income producing real estate. This article walks through 3 stocks that appear particularly...

Celsius Holdings stock is in a tricky spot for valuation right now, with the share price weak over recent years while broader checks still suggest the stock is not a clear bargain. Recent legal and regulatory scrutiny around its Alani Nu energy drinks has added another layer of uncertainty on top of already cautious market sentiment. Over the past 3 years, Celsius Holdings has delivered a total return that is down about 41%, which shows how much optimism has already come out of the share...

AXT stock has delivered an extremely strong 1 year return while the broader valuation checks currently lean expensive. This raises the question of how much of the AI and optical networking enthusiasm is already reflected in the price. AXT has returned 3,486.1% over the past year, a very large move that leaves little room for disappointment if expectations reset. Expectations around AI data center and optical networking demand, supported by capacity expansion plans and a record backlog, can...

Why Agnico Eagle Mines Stock Is Back in Focus Agnico Eagle Mines (NYSE:AEM) has drawn attention after its stock fell 2.21% in the latest session and the company confirmed dates for its upcoming second quarter 2026 earnings release and conference call. See our latest analysis for Agnico Eagle Mines. For context, Agnico Eagle Mines is trading at $155.13, with the share price down 15.3% over the past 30 days and 26.2% over 90 days, even as the 1 year total shareholder return sits at 32.7% and...

FB Financial Corporation has announced it will release its second-quarter 2026 results on July 13 after market close, followed by an earnings call on July 14, and has authorized a new US$175,000,000 share repurchase program running through June 30, 2027. This combination of an upcoming earnings update and a sizeable buyback authorization highlights management’s confidence and has drawn fresh attention from analysts. We’ll now explore how the newly authorized US$175,000,000 share repurchase...